Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia

Michelle A. Neben, William G. Morice, Ayalew Tefferi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: Standard clinical and laboratory evaluations and novel laboratory techniques were used to identify patients with T-cell large granular lymphocyte leukemia (LGLL) and those with natural killer-cell variants of LGLL for comprehensive clinical evaluation. Methods: We used bone marrow histologic analysis, immunophenotypic markers of clonality, and T-cell-receptor gene rearrangement studies to identify patients. Results: The study identified 44 patients with T-cell LGLL and 14 with natural killer-cell LGLL. The two disorders were similar in sex and age distribution of patients; peripheral blood lymphocyte, neutrophil, and platelet counts; and incidence of rheumatoid arthritis. Among the two groups, patients with the T-cell LGLL presented with significantly lower hemoglobin concentrations (P < 0.04) and a higher frequency of palpable splenomegaly (P < 0.01). Conclusion: Overall disease progression and response to immunosuppressive therapy are similar between T-cell and natural killer-cell variants of LGLL.

Original languageEnglish (US)
Pages (from-to)263-265
Number of pages3
JournalEuropean Journal of Haematology
Volume71
Issue number4
DOIs
StatePublished - Oct 1 2003

Fingerprint

Large Granular Lymphocytic Leukemia
Natural Killer Cells
T-Lymphocytes
T-Lymphocyte Gene Rearrangement
T-Cell Receptor Genes
Sex Distribution
Splenomegaly
Age Distribution
Lymphocyte Count
Immunosuppressive Agents
Platelet Count
Disease Progression
Rheumatoid Arthritis
Neutrophils
Bone Marrow
Incidence

Keywords

  • Immunophenotype
  • Killing inhibitory receptor
  • Large granular lymphocyte
  • Natural killer cell
  • T-cell

ASJC Scopus subject areas

  • Hematology

Cite this

Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia. / Neben, Michelle A.; Morice, William G.; Tefferi, Ayalew.

In: European Journal of Haematology, Vol. 71, No. 4, 01.10.2003, p. 263-265.

Research output: Contribution to journalArticle

@article{7cdb33867209446188a9858074cd93e8,
title = "Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia",
abstract = "Objective: Standard clinical and laboratory evaluations and novel laboratory techniques were used to identify patients with T-cell large granular lymphocyte leukemia (LGLL) and those with natural killer-cell variants of LGLL for comprehensive clinical evaluation. Methods: We used bone marrow histologic analysis, immunophenotypic markers of clonality, and T-cell-receptor gene rearrangement studies to identify patients. Results: The study identified 44 patients with T-cell LGLL and 14 with natural killer-cell LGLL. The two disorders were similar in sex and age distribution of patients; peripheral blood lymphocyte, neutrophil, and platelet counts; and incidence of rheumatoid arthritis. Among the two groups, patients with the T-cell LGLL presented with significantly lower hemoglobin concentrations (P < 0.04) and a higher frequency of palpable splenomegaly (P < 0.01). Conclusion: Overall disease progression and response to immunosuppressive therapy are similar between T-cell and natural killer-cell variants of LGLL.",
keywords = "Immunophenotype, Killing inhibitory receptor, Large granular lymphocyte, Natural killer cell, T-cell",
author = "Neben, {Michelle A.} and Morice, {William G.} and Ayalew Tefferi",
year = "2003",
month = "10",
day = "1",
doi = "10.1034/j.1600-0609.2003.00136.x",
language = "English (US)",
volume = "71",
pages = "263--265",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia

AU - Neben, Michelle A.

AU - Morice, William G.

AU - Tefferi, Ayalew

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Objective: Standard clinical and laboratory evaluations and novel laboratory techniques were used to identify patients with T-cell large granular lymphocyte leukemia (LGLL) and those with natural killer-cell variants of LGLL for comprehensive clinical evaluation. Methods: We used bone marrow histologic analysis, immunophenotypic markers of clonality, and T-cell-receptor gene rearrangement studies to identify patients. Results: The study identified 44 patients with T-cell LGLL and 14 with natural killer-cell LGLL. The two disorders were similar in sex and age distribution of patients; peripheral blood lymphocyte, neutrophil, and platelet counts; and incidence of rheumatoid arthritis. Among the two groups, patients with the T-cell LGLL presented with significantly lower hemoglobin concentrations (P < 0.04) and a higher frequency of palpable splenomegaly (P < 0.01). Conclusion: Overall disease progression and response to immunosuppressive therapy are similar between T-cell and natural killer-cell variants of LGLL.

AB - Objective: Standard clinical and laboratory evaluations and novel laboratory techniques were used to identify patients with T-cell large granular lymphocyte leukemia (LGLL) and those with natural killer-cell variants of LGLL for comprehensive clinical evaluation. Methods: We used bone marrow histologic analysis, immunophenotypic markers of clonality, and T-cell-receptor gene rearrangement studies to identify patients. Results: The study identified 44 patients with T-cell LGLL and 14 with natural killer-cell LGLL. The two disorders were similar in sex and age distribution of patients; peripheral blood lymphocyte, neutrophil, and platelet counts; and incidence of rheumatoid arthritis. Among the two groups, patients with the T-cell LGLL presented with significantly lower hemoglobin concentrations (P < 0.04) and a higher frequency of palpable splenomegaly (P < 0.01). Conclusion: Overall disease progression and response to immunosuppressive therapy are similar between T-cell and natural killer-cell variants of LGLL.

KW - Immunophenotype

KW - Killing inhibitory receptor

KW - Large granular lymphocyte

KW - Natural killer cell

KW - T-cell

UR - http://www.scopus.com/inward/record.url?scp=0141763451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141763451&partnerID=8YFLogxK

U2 - 10.1034/j.1600-0609.2003.00136.x

DO - 10.1034/j.1600-0609.2003.00136.x

M3 - Article

C2 - 12950235

AN - SCOPUS:0141763451

VL - 71

SP - 263

EP - 265

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 4

ER -